HUDDINGE, Sweden, May 16, 2023 /PRNewswire/ — In light of the incentive program adopted by the annual general meeting of Medivir AB (publ) (“Medivir”) on 4 May 2023 (“LTIP 2023”), it is today announced that the board of directors of Medivir has resolved on (i) a share issue of 970,500…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.